10x Genomics director John R. Stuelpnagel disposes of USD 1.25 million in common shares

• 10x Genomics director John R. Stuelpnagel sold 19,000 Class A common shares on Sept. 3, 2026.
• Sales were priced at a weighted average of USD 60.66 to USD 62.61 per share.
• His direct holding fell to 328,436 shares following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 10x Genomics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001610717-26-000405), on September 08, 2026, and is solely responsible for the information contained therein.